期刊文献+

嗜铬细胞瘤/副神节瘤的围手术期处理 被引量:4

Perioperative management for pheochromocytoma/paraganglioma
下载PDF
导出
摘要 嗜铬细胞瘤/副神节瘤是由神经嵴起源的嗜铬细胞产生的肿瘤,具有分泌儿茶酚胺的功能,而儿茶酚胺作用于血管、心脏,常常引起血液循环系统及代谢的改变。嗜铬细胞瘤手术前后血液中儿茶酚胺浓度的变化会引起相应血液动力学的改变,若没有充分的术前准备和术后监护,心血管意外事件的发生几率很高。因此,了解嗜铬细胞瘤/副神节瘤的病理学特点,术前进行良好的药物准备,术中轻柔的手术操作及与麻醉师的良好配合,术后ICU的严密监护,是嗜铬细胞瘤围手术期处理的关键,也是嗜铬细胞瘤/副神节瘤成功治疗的基本保障。 Pheochromocytoma/paraganglioma is a tumor originated from the neural crest,which can secrete catecholamine,while catecholamine can affect the metabolism and blood circulatory system.The changes of catecholamine concentration in blood before and after surgery will affect hemodynamics.Without adequate preoperative preparation and postoperative care,the incidence of cardiovascular events is high.Therefore,good understanding of the pathophysiologcal characteristics of pheochromocytoma/paraganglioma,careful preparation of drugs before operation,gentle surgical operation and good cooperation between surgeons and anesthetists during operation,and intensive care in ICU after operation are the key components of perioperative management and the basis for successful treatment.
出处 《现代泌尿外科杂志》 CAS 2012年第4期329-332,共4页 Journal of Modern Urology
关键词 嗜铬细胞瘤/副神节瘤 儿茶酚胺 围手术期 pheochromocytoma/paraganglioma catecholamine perioperative period
  • 相关文献

参考文献17

  • 1RENARD J, CLERICI T, LICKER M, et al. Pheochromocyto- ma and abdominal paraganglioma[J]. J Visc Surg, 2011, 148 (6) : e409-416.
  • 2KOBAYASHI T, IWAI A, TAKAHASHI R, et al. Spontane- ous rupture of adrenal pheochromocytoma: review and analysis of prognostic faetors[J]. J Surg Oncol, 2005, 90(1) :31-35.
  • 3PLOUIN PF, DUCLOS JM, SOPPELSA F, et al. Factors asso- ciated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165operations at a single center [J]. JClinEndocrinolMetab, 2001, 86(4): 1480-1486.
  • 4PARNABY CN, SERPELL MG, CONNELL JM, et al. Periop- erative haemodynamic changes in patients undergoing laparo- scopic adrenalectomy for phaeochromocytomas and other adrenal tumours[J]. Surgeon, 2010, 8 ( 1 ) : 9-14.
  • 5GUERRERO MA, SCHREINEMAKERS JM, VRIENS MR,et al. Clinical spectrum of pheoehromocytoma[J]. J AM Coll Surg, 2009, 209(6) :727-732.
  • 6VAN BRAECKEL P, CARLIER S, STEELANT PJ, et al. Perioperative management of phaeochromocytoma[J]. Acta An- aesthesiol Belg, 2009, 60(1):55-66.
  • 7PACAK K, EISENHOFER G, AHLMAN H, et al. Pheochro- mocytoma: recommendations for clinical practice from the first international symposium[J]. Nat Clin Pract Endocrinol Metab, 2007, 3(2): 92-102.
  • 8MCMILLIAN WD, TROMBLEY BJ, CHARASH WE, et al. Phentolamine continuous infusion in a patient with pheochromo- cytoma[J]. AmJ HealthSyst Pharm, 2011, 68(2) :130-134.
  • 9KNuTTGEN D, WAPPLER F. Anaesthesia for patients with phaeochromocytoma-specifies, potential complications and drug strategles[J]. Anasthesiol Intensivmed Notfallmed Schrnerz ther, 2008, 43(1) :20-27.
  • 10夏溟,李汉忠,刘广华,严维刚,袁铭,臧美孚.嗜铬细胞瘤术前准备的临床体会(附286例报告)[J].中华泌尿外科杂志,2004,25(12):816-818. 被引量:36

二级参考文献4

  • 1James CU, David AG, Bravo EL,et al. Successful outcomes in pheochromocytoma surgery in the modem era. J Urol, 1999,161:764-676.
  • 2Stenstrom, Kutti J. The blood volume in pheochromcytoma. Acta Med Scand, 1985 ,218 :381-383.
  • 3Malome M J, Libertino JA ,Tsapatsaris NP, et al. Preoperative and surgical management of pheochromocytoma. Urol Clin North Am, 1989,16:567-570.
  • 4Richard EG,James AO Jr,Geoge WH,et al. Clinical experience over 48 years with pheochromocvtoma. Ann Surg, 1999,229:756-766.

共引文献35

同被引文献44

  • 1夏溟,李汉忠,刘广华,严维刚,袁铭,臧美孚.嗜铬细胞瘤术前准备的临床体会(附286例报告)[J].中华泌尿外科杂志,2004,25(12):816-818. 被引量:36
  • 2Renard J, Clerici T, Licker M, et al. Pheochromocyto- ma and abdominal paraganglioma [- J 1. J Visc Surg, 2011, 148(6): e409-416.
  • 3Neumann H P, Vortmeyer A, Schmidt D, et al. Evi- dence of MEN-2 in the original description of classic pheochromocytomaFJ~. N Engl J Med, 2007, 357. 1311-1315.
  • 4Elder E E, Elder G, Larsson C. Pheochromocytoma and functional paraganglioma syndrome., no longer the 10% tumor[-J~. J Surg Oncol, 2005, 89: 193-201.
  • 5Amar L, Bertherat J, Baudin E, et al. Genetic testing in pheochromocytoma or functional paragangliomal-J-]. J Clin Oncol, 2005, 23:8812-8818.
  • 6Benn D E, Gimenez-Roqueplo A P, Reilly J R, et al. Clinical presentation and penetrance of pheochromocy- toma/paraganglioma syndromesl-J~. J clin Endocrinol Metab, 2006, 91:827-836.
  • 7Timmer H J, Kozupa A, Eisenhofer G, et al. Clinical presentation, biochemical phenotypes, and genotype- phenotype correlations in patients with succinate dehy- drogenase subunit B-associated pheochromocytoma and paragangliomarJ']. J Clin Endocrinol Metab, 2007, 92. 779-786.
  • 8Pacak K, Eisenhofer G, llias I. Diagnosis of pheochro- mocytoma with special emphasis on MEN2 syndrome [J]. Hormones(Athens), 2009, 8.111. 116.
  • 9Samuels M A, Pomerantz B J, Sado W P M. Case re- cords of the Massachusetts General Hospital. Case 14 -2010. A 54-year-old woman with dizziness and falls [J]. NEnglJ Med, 2010, 362: 1815-1823.
  • 10Dolan R T, Butler J S, Mentee G P, et al. Pheochro- mocytoma presenting as recurrent urinary tract infec- tions :a case report[J]. J Med Case Reports, 2011, 5: 6.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部